Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy

被引：0
|
作者：
Taiichi Hikichi
机构：
[1] Ohtsuka Eye Hospital,
来源：
BMC Ophthalmology | / 15卷
关键词：
Individualized therapy; Polypoidal choroidal vasculopathy; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Treatment of polypoidal choroidal vasculopathy with photodynamic therapy
    Spaide, RF
    Donsoff, I
    Lam, DL
    Yannuzzi, LA
    Jampol, LM
    Slakter, J
    Sorenson, J
    Freund, KB
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (05): : 529 - 535
  • [32] Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
    Miura, Masahiro
    Iwasaki, Takuya
    Goto, Hiroshi
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1591 - 1595
  • [33] CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Kikushima, Wataru
    Kume, Atsuki
    Iijima, Hiroyuki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1866 - 1872
  • [34] Hemorrhagic complications after intravitreal ranibizumab injection for polypoidal choroidal vasculopathy
    Cho, Han Joo
    Lee, Dong Won
    Cho, Sung Won
    Kim, Chul Gu
    Kim, Jong Woo
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2012, 47 (02): : 170 - 175
  • [35] Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
    Tan, Colin S.
    Lim, Louis W.
    Margaron, Philippe
    OPHTHALMOLOGY SCIENCE, 2022, 2 (01):
  • [36] Factors associated with retreatment after photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy
    Kikushima, Wataru
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Yoneyama, Seigo
    Iijima, Hiroyuki
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [37] Choroidal remodeling after photodynamic therapy for polypoidal choroidal vasculopathy
    Tan, Colin S.
    Lim, Louis W.
    Ting, Dominic S.
    LASERS IN SURGERY AND MEDICINE, 2018, 50 (10) : 978 - 979
  • [38] CORRELATION BETWEEN CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AND 1-YEAR OUTCOMES OF RANIBIZUMAB THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Hikichi, Taiichi
    Kitamei, Hirokuni
    Shioya, Shoko
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kimitaka
    Ohtsuka, Hideo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [39] Relation between changes in foveal choroidal thickness and 1-year results of ranibizumab therapy for polypoidal choroidal vasculopathy
    Hikichi, Taiichi
    Kitamei, Hirokuni
    Shioya, Shoko
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kimitaka
    Ohtsuka, Hideo
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) : 1201 - 1204
  • [40] Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy
    Sakai, Tsutomu
    Okano, Kiichiro
    Kohno, Hideo
    Tsuneoka, Hiroshi
    ACTA OPHTHALMOLOGICA, 2016, 94 (08) : E765 - E771
12345